MetaCap

Pulmatrix (PULM) vs Universe Pharmaceuticals (UPC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Universe Pharmaceuticals is the larger company by market cap ($5.4 million vs $4.6 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PULM-14.77%UPC-74.91%
+9%-35%-79%
Oct 7, 20261 yearNov 20, 2026
PULM-13.01%UPC-73.98%
+9%-35%-78%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PULM versus UPC key metrics
MetricPULMUPC
Share price$1.27$1.08
Market cap$4.64M$5.43M
1-day change-10.56%-20.59%
YTD return—-71.65%
1-year return—-68.24%
5-year return—-99.99%
EPS (TTM)$-1.20$-1.38
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$17.86B
Revenue growth (YoY)—-22.44%
Net income (latest FY)$-5.16M$-3.67B
Gross margin—35.28%
Operating margin—-16.33%
Net margin—-20.56%
52-week high$4.94$17.96
52-week low$1.06$1.05
Distance from 52-week high-74.29%-93.99%
Average volume35.45K176.76K
Shares outstanding3.65M5.01M
Employees2216
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Pulmatrix

PULM stock →

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

About Universe Pharmaceuticals

UPC stock →

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.

Health Care · Biotechnology: Pharmaceutical Preparations · 216 employees

PULM vs UPC FAQ

Which is bigger, Pulmatrix or Universe Pharmaceuticals?

Universe Pharmaceuticals (UPC) is larger, with a market capitalization of $5.43M compared with $4.64M for Pulmatrix (PULM).

Are Pulmatrix and Universe Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons